Bright Minds Biosciences Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
DRUG Nasdaq 2836 brightmindsbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Bright Minds Biosciences Inc.

Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipeline - May 21st, 2026 3:51 pm
What Is the Probability of Success for Bright Minds Biosciences Inc (DRUG)’s Lead Drug Candidate? - Mar 24th, 2026 11:34 pm
Psychedelic: Helus Pharma reports HLP004 Phase 2 signal detection study results - Mar 6th, 2026 8:15 am
Bright Minds Biosciences to Present at Upcoming Conferences - Feb 25th, 2026 2:30 pm
Baird Lowers Bright Minds Biosciences Inc. (DRUG) Price Target to $126, Maintains Outperform Rating Ahead of Upcoming Trials - Feb 18th, 2026 7:31 pm
Canadian Securities Exchange Reports January 2026 Performance Figures - Feb 17th, 2026 8:09 am
Bright Minds Biosciences Announces Closing of US$175 Million Public Offering - Jan 9th, 2026 9:56 am
Bright Minds Biosciences Announces Pricing of Upsized US$175 Million Public Offering of Common Stock - Jan 7th, 2026 7:33 pm
Bright Minds Biosciences Announces Launch of US$100 Million Public Offering - Jan 6th, 2026 2:00 pm
Bright Minds Biosciences Announces Positive Topline Results from Phase 2 Clinical Trial of BMB-101 in Patients with Absence Seizures and Developmental and Encephalopathic Epilepsies (DEE) - Jan 6th, 2026 5:16 am
Bright Minds to Announce Topline Results for BMB-101 Phase 2 Trial in Absence Seizures and Developmental and Epileptic Encephalopathies on Tuesday, January 6, 2026 - Jan 5th, 2026 2:30 pm
Recent Price Trend in Bright Minds Biosciences Inc. (DRUG) is Your Friend, Here's Why - Nov 26th, 2025 6:55 am
Bright Minds Biosciences to Present at Piper Sandler 37th Annual Healthcare Conference and 2025 AES Annual Meeting - Nov 25th, 2025 2:30 pm
Wall Street Analysts Think Bright Minds Biosciences Inc. (DRUG) Could Surge 36.27%: Read This Before Placing a Bet - Nov 25th, 2025 7:55 am
Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Experts in Prader-Willi Syndrome (PWS) - Nov 17th, 2025 4:50 am
Bright Minds Biosciences Initiates New Prader-Willi Syndrome (PWS) Program; KOL Event Scheduled for November 6TH - Nov 6th, 2025 4:30 am
Bright Minds Biosciences Inc. (DRUG) is on the Move, Here's Why the Trend Could be Sustainable - Oct 15th, 2025 6:50 am
Wall Street Analysts Believe Bright Minds Biosciences Inc. (DRUG) Could Rally 81.29%: Here's is How to Trade - Sep 18th, 2025 7:55 am
Large Patient Population Is Key Driver For Bright Minds' Growth - Sep 8th, 2025 11:54 am
Weekly Roundup on the Cannabis Sector & Psychedelic Sector - Sep 7th, 2025 3:29 pm